Trials / Completed
CompletedNCT01961167
Evaluation of the GORE® VIABAHN® BALLOON EXPANDABLE ENDOPROSTHESIS (VIABAHN BX)
Evaluation of the GORE® VIABAHN® BALLOON EXPANDABLE ENDOPROSTHESIS (VIABAHN BX) for the Treatment of Occlusive Disease in the Common and External Iliac Arteries
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 27 (actual)
- Sponsor
- W.L.Gore & Associates · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of the VBX13-05 clinical study is to evaluate the safety and efficacy of VIABAHN BX for the treatment of arterial occlusive disease in patients with de novo or restenotic lesions in the common and/or external iliac arteries.
Conditions
- Common Iliac Artery Occlusive Disease
- External Iliac Artery Occlusive Disease
- Peripheral Arterial Disease
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Stenting of common and/or external iliacs | Balloon expandable stenting of iliac occlusive disease |
Timeline
- Start date
- 2013-12-01
- Primary completion
- 2015-01-01
- Completion
- 2017-12-14
- First posted
- 2013-10-11
- Last updated
- 2019-11-19
- Results posted
- 2019-11-06
Locations
1 site across 1 country: New Zealand
Source: ClinicalTrials.gov record NCT01961167. Inclusion in this directory is not an endorsement.